TUCSON, Ariz., July 22, 2025 — Stakeholders across the life sciences ecosystem are invited to attend the 2025 Critical Path Institute® (C-Path) Global Impact Conference (CGIC), taking place Sept. 9–11 ...
Critical Path Institute’s® Translational Therapeutics Accelerator today officially launched its 2026 global Request for Proposals for Bridging Research and Innovation in Drug Development Grants. These ...
Critical Path Institute’s Translational Therapeutics Accelerator has invested in the development of QED-203 for advanced and therapy-resistant prostate cancer. Based on research at the University of ...